Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Diabetic retinopathy and atherosclerosis: is there a link?

Ellis TP, Choudhury RH, Kaul K, Chopra M, Kohner EM, Tarr JM, Chibber R.

Curr Diabetes Rev. 2013 Mar 1;9(2):146-60. Review.

PMID:
23094754
2.

Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

Ola MS, Nawaz MI, Siddiquei MM, Al-Amro S, Abu El-Asrar AM.

J Diabetes Complications. 2012 Jan-Feb;26(1):56-64. doi: 10.1016/j.jdiacomp.2011.11.004. Epub 2012 Jan 5. Review.

PMID:
22226482
3.

[Biochemical mechanisms in the pathogeny of diabetic retinopathy].

Zamfir C.

Oftalmologia. 2009;53(2):8-12. Review. Romanian.

PMID:
19697833
4.

Diabetic retinopathy--biomolecules and multiple pathophysiology.

Ahsan H.

Diabetes Metab Syndr. 2015 Jan-Mar;9(1):51-4. doi: 10.1016/j.dsx.2014.09.011. Epub 2014 Oct 24. Review.

PMID:
25450817
5.
6.

AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view.

Chilelli NC, Burlina S, Lapolla A.

Nutr Metab Cardiovasc Dis. 2013 Oct;23(10):913-9. doi: 10.1016/j.numecd.2013.04.004. Epub 2013 Jun 17. Review.

PMID:
23786818
7.

Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy.

Yamagishi S, Takeuchi M, Inagaki Y, Nakamura K, Imaizumi T.

Int J Clin Pharmacol Res. 2003;23(4):129-34. Review.

PMID:
15224502
8.

Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.

Wan TT, Li XF, Sun YM, Li YB, Su Y.

Biomed Pharmacother. 2015 Aug;74:145-7. doi: 10.1016/j.biopha.2015.08.002. Epub 2015 Aug 13. Review.

PMID:
26349976
9.

Biochemistry and molecular cell biology of diabetic complications.

Brownlee M.

Nature. 2001 Dec 13;414(6865):813-20.

PMID:
11742414
10.

Advanced glycation end products (AGEs) and diabetic vascular complications.

Yamagishi S, Nakamura K, Imaizumi T.

Curr Diabetes Rev. 2005 Feb;1(1):93-106. Review.

PMID:
18220586
11.

Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.

Cooper ME.

Am J Hypertens. 2004 Dec;17(12 Pt 2):31S-38S. Review.

PMID:
15607433
12.

Metabolic memory: mechanisms and implications for diabetic retinopathy.

Zhang L, Chen B, Tang L.

Diabetes Res Clin Pract. 2012 Jun;96(3):286-93. doi: 10.1016/j.diabres.2011.12.006. Epub 2011 Dec 29. Review.

PMID:
22209677
13.

The role of advanced glycation in the pathogenesis of diabetic retinopathy.

Stitt AW.

Exp Mol Pathol. 2003 Aug;75(1):95-108. Review.

PMID:
12834631
14.

RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation.

Li Y, Liu S, Zhang Z, Xu Q, Xie F, Wang J, Ping S, Li C, Wang Z, Zhang M, Huang J, Chen D, Hu L, Li C.

PLoS One. 2012;7(4):e35016. doi: 10.1371/journal.pone.0035016. Epub 2012 Apr 9.

15.

Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.

Stitt AW, Frizzell N, Thorpe SR.

Curr Pharm Des. 2004;10(27):3349-60. Review.

PMID:
15544520
16.

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Yamagishi S, Imaizumi T.

Curr Pharm Des. 2005;11(18):2279-99. Review.

PMID:
16022668
17.

Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice.

Zhang SY, Li BY, Li XL, Cheng M, Cai Q, Yu F, Wang WD, Tan M, Yan G, Hu SL, Gao HQ.

Mol Vis. 2013 Apr 5;19:812-21. Print 2013.

18.

Eye complications and markers of morbidity and mortality in long-term type 1 diabetes.

Grauslund J.

Acta Ophthalmol. 2011 Feb;89 Thesis 1:1-19. doi: 10.1111/j.1755-3768.2010.02105.x.

19.

[Role of hyperglycemia in the development of diabetic microangiopathy].

Miyata S, Kasuga M.

Nihon Rinsho. 2005 Jun;63 Suppl 6:45-51. Review. Japanese. No abstract available.

PMID:
15999684
20.

Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy.

Yamagishi S, Nakamura K, Matsui T.

Curr Drug Discov Technol. 2006 Mar;3(1):83-8. Review.

PMID:
16712466

Supplemental Content

Support Center